Vikas Goyal is a Partner at Longwood Fund. He has experience in corporate strategy and investments within the biotechnology industry.

What Vikas can write

Writes checks ofNot reported
Comes in atPre-seed, Seed, Series ACan lead the round
Ownership target7-10%At first check
Email the firm[email protected]The firm's own inbox for founders.

Career

  1. McKinsey & Co · Consultant
  2. Extera Partners
  3. Infinity Pharmaceuticals · Business Development Manager
  4. SR One
  5. Pandion Therapeutics · Senior Vice President of Business Development
    2019-2021
  6. Trekk Venture Partners · Managing Partner
  7. Longwood Fund · Partner
    Now

Companies founded

Extera Partners

Investments named in public bios

Morphic TherapeuticsRiver Vision DevelopmentNimbus TherapeuticsSpero TherapeuticsPandion

Focus

biotechcorporate strategycapital formationcorporate partnershipsM&A

Education

Harvard University, BA in NeurobiologyWharton School of the University of Pennsylvania, MBA in Health Care Management

Also at Longwood Fund

Partners like Vikas

At firms with a similar stage, sector and check size.

Alert me when Longwood Fund is active

One email when Vikas's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Vikas Goyal?

Vikas Goyal is a Partner at Longwood Fund. He has experience in corporate strategy and investments within the biotechnology industry.

How much does Vikas Goyal invest?

Longwood Fund has not reported a check size. It invests at pre-seed, seed, series a.

How do I pitch Vikas Goyal?

Email [email protected], the firm's inbox for founders, and name Vikas in the subject. A warm intro from a founder Longwood Fund backed works better.

What did Vikas Goyal do before Longwood Fund?

Consultant at McKinsey & Co; Extera Partners; Business Development Manager at Infinity Pharmaceuticals; SR One; Senior Vice President of Business Development at Pandion Therapeutics; Managing Partner at Trekk Venture Partners.

Last updated 2026-10-15. Is this you? Ask for a correction.